GlassScriptPhysician profile
Robert C Homburg
NPI 1811918451
$2,194.89
in general payments reported to CMS, 2019-2025
34 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,128 · 2020: $441 · 2021: $499 · 2022: $127.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $230.07 | 2019-2022 | |
| Amgen INC. | $226.52 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $193.37 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $178.54 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $163.90 | 2019-2022 | |
| Radius Health, INC. | $144.24 | 2019-2020 | |
| Pfizer INC. | $111.11 | 2019-2021 | |
| Allergan, INC. | $100.57 | 2019-2020 | |
| Senseonics, Incorporated | $71.00 | 2019 | |
| Merck Sharp & Dohme LLC | $68.97 | 2019-2020 | |
| Lilly USA, LLC | $65.67 | 2019-2021 | |
| Alfasigma USA, INC. | $53.32 | 2020-2022 | |
| Glaxosmithkline, LLC. | $47.11 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $43.00 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $41.70 | 2019-2020 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $37.89 | 2021 | |
| Eisai INC. | $37.50 | 2021 | |
| Daiichi Sankyo INC. | $31.59 | 2019-2020 | |
| Ge Healthcare | $31.18 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.10 | 2020-2021 | |
| Sanofi Pasteur INC. | $28.95 | 2019 | |
| Nestle Healthcare Nutrition INC. | $26.36 | 2022 | |
| Abbvie INC. | $24.13 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $24.07 | 2021 | |
| Amarin Pharma, INC. | $22.45 | 2021 | |
| Esperion Therapeutics, INC. | $21.63 | 2021 | |
| Novo Nordisk INC | $20.70 | 2021 | |
| Astellas Pharma US INC | $18.99 | 2021 | |
| Alnylam Pharmaceuticals INC. | $18.64 | 2021 | |
| Ibsa Pharma INC. | $18.58 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $18.53 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $17.18 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.90 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.43 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Homburg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.